Clinical characteristics and treatment outcomes of severe (ICU) COVID-19 patients in Saudi Arabia: A single centre study
Saleh Alghamdi
Saudi Pharmaceutical Journal, doi:10.1016/j.jsps.2021.08.008
Background: There is limited information describing the presenting features and treatment outcomes of intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19) in Saudi Arabia. Objective: To investigates the clinical, epidemiological, laboratory, radiological, vital signs and treatment characteristics/outcomes of severe (ICU) COVID-19 patients in Albaha region, Saudi Arabia. Methods: A retrospective cohort study was conducted from 01 April 2020 to 31 August 2020 involving files review of 171 patients admitted to the ICU of a COVID-19 treatment centre as a result of severe symptoms. Results: Around a third of the ICU patients admitted were over 66 years of age, 59.6% males, 45% diabetics, 39% hypertensive, 25.7% smokers. Patients had symptoms such as 79% fever, 78% cough, 75% headache, 59% sore throat, 57% runny nose, and 75% cough. More than half of the patients had <90% oxygen saturation. Bilateral infiltration was present in about 43% of patients. 85.4% lymphopenia, and 70.8% D-dimer (>0.5 u/ml) were the most significant laboratory results. The median stay in the hospital ranged from 4 to 15.6 days, and the ICU time ranged from 4 to 12.7 days. Approximately 29% of patients received antiviral, antimalarial, and antibiotic treatment, while 27.5% of patients received antibiotics and antimalarial therapy alone. Incorporating hydroxychloroquine in treatment protocols did not improve patients' outcomes. Conclusions: Older age and cardio-metabolic comorbidities increase the risks of sever COVID-19. Different treatment protocols fail to improve mortality rates and urgent efforts are required to prevent the disease and reduce its severity.
References
Alghamdi, Barakat, Berrou, Alzahrani, Haseeb et al., Clinical efficacy of hydroxychloroquine in patients with COVID-19: Findings from an observational comparative study in Saudi Arabia, Antibiotics,
doi:10.3390/antibiotics10040365Alharthy, Aletreby, Faqihi, Balhamar, Alaklobi et al., Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: A retrospective study, J. Epidemiol. Glob. Health,
doi:10.2991/JEGH.K.200928.001Alhumaid, Al Mutair, Al Alawi, Al Salman, Al Dossary et al., Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia, Eur. J. Med. Res,
doi:10.1186/s40001-021-00517-7Alsofayan, Althunayyan, Khan, Hakawi, Assiri, Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study, J. Infect. Public Health,
doi:10.1016/j.jiph.2020.05.026Alwafi, Naser, Qanash, Brinji, Ghazawi et al., Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in Saudi Arabia: A cross-sectional study, J. Multidiscip. Healthc,
doi:10.2147/JMDH.S304788Alyami, Naser, Orabi, Alwafi, Alyami, Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: An Ecological Study, Front. Public Heal,
doi:10.3389/fpubh.2020.00506Arentz, Yim, Klaff, Lokhandwala, Riedo et al., Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State, J. Am. Med. Assoc,
doi:10.1001/jama.2020.4326Auwaerter, Coronavirus COVID-19 (SARS-CoV-2)
Barry, Althabit, Akkielah, Almohaya, Alotaibi et al., Clinical characteristics and outcomes of hospitalized COVID-19 patients in a MERS-CoV referral hospital during the peak of the pandemic, Int. J. Infect. Dis,
doi:10.1016/j.ijid.2021.03.058Bhimraj, Morgan, Shumaker, Lavergne, Baden et al., Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with Coronavirus Disease 2019 (COVID-19), Clin. Infect. Dis,
doi:10.1093/cid/ciaa478Briguglio, Crespi, Pino, Mazzocchi, Porta et al., Clinical Characteristics of Severe COVID-19 Patients Admitted to an Intensive Care Unit in Lombardy During the Italian Pandemic,
doi:10.3389/fmed.2021.582896Caliskan, Saylan, Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: A retrospective observational study, Rev. Assoc. Med. Bras,
doi:10.1590/1806-9282.66.12.1679Casas-Rojo, Anton-Santos, Millan-Nunez-Cortes, Lumbreras-Bermejo, Ramos-Rincon et al., Clinical characteristics of patients hospitalized with COVID-19 in Spain : results from the SEMI-COVID-19 Registry,
doi:10.1016/j.rceng.2020.07.003Chedid, Waked, Haddad, Chetata, Saliba et al., Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy, J. Infect. Public Health,
doi:10.1016/j.jiph.2021.02.001Chen, Wu, Chen, Yan, Yang et al., Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study, BMJ,
doi:10.1136/bmj.m1091Diamond, Feliciano, Sanghavi, Mahapatra, Acute Respiratory Distress Syndrome. StatPearls [Internet
Gadhiya, Hansrivijit, Gangireddy, Goldman, Clinical characteristics of hospitalised patients with COVID-19 and the impact on mortality: A single-network, retrospective cohort study from Pennsylvania state, BMJ Open,
doi:10.1136/bmjopen-2020-042549Guo, Fan, Chen, Wu, Zhang et al., Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19), JAMA Cardiol,
doi:10.1001/jamacardio.2020.1017Gülsen, Yigitbas, Uslu, Drömann, Kilinc, The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis, Pulm. Med,
doi:10.1155/2020/7590207Hammad, Abdo, Mashaly, Syed Sulaiman, Alghamdi et al., The statins effects on HbA1c control among diabetic patients: An umbrella review of systematic reviews and meta-analyses of observational studies and clinical trials, Diabetes Metab. Syndr. Clin. Res. Rev,
doi:10.1016/j.dsx.2019.07.005Hammad, Sulaiman, Aziz, Noor, Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice, J. Res. Med. Sci,
doi:10.4103/jrms.JRMS_100_18Hammad, Syed Sulaiman, Alghamdi, Mangi, Aziz et al., Statins-related peripheral neuropathy among diabetic patients, Diabetes Metab. Syndr. Clin. Res. Rev,
doi:10.1016/j.dsx.2020.04.005Hammad, Tangiisuran, Kharshid, Abdul-Aziz, Hassan et al., Drug-drug Interaction-related Uncontrolled Glycemia, J. Pharm. Bioallied Sci,
doi:10.4103/jpbs.JPBS_26_17Hopkins, None
Jomah, Asdaq, Al-Yamani, Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review, J. Infect. Public Health,
doi:10.1016/j.jiph.2020.07.013Kermali, Khalsa, Pillai, Ismail, Harky, The role of biomarkers in diagnosis of COVID-19 -A systematic review, Life Sci,
doi:10.1016/j.lfs.2020.117788Mangi, Hammad, Khan, Arain, Shahzad et al., Evaluation of the geriatric patients prescription for inappropriate medications frequency at Larkana Sindh Hospital in Pakistan, Clin. Epidemiol. Glob. Heal,
doi:10.1016/j.cegh.2020.06.001Mardani, Vasmehjani, Zali, Gholami, Mousavi Nasab et al., Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study, Arch. Acad. Emerg. Med,
doi:10.22037/aaem.v8i1.632Monard, Textoris, Rimmele, Montini, Lejour et al., Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study, Intensive Care Med,
doi:10.1007/s00134-020-06294-xPatanavanich, Glantz, Smoking is associated with COVID-19 progression: A meta-analysis, Nicotine Tob. Res,
doi:10.1093/ntr/ntaa082Peckham, De Gruijter, Raine, Radziszewska, Ciurtin et al., Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission, Nat. Commun,
doi:10.1038/s41467-020-19741-6Rawshani, Kjölhede, Rawshani, Sattar, Eeg-Olofsson et al., Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study, Lancet Reg. Heal. -Eur,
doi:10.1016/j.lanepe.2021.100105Rees, Nightingale, Jafari, Waterlow, Clifford et al., COVID-19 length of hospital stay: A systematic review and data synthesis, BMC Med,
doi:10.1186/s12916-020-01726-3Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area, JAMA -J. Am. Med. Assoc,
doi:10.1001/jama.2020.6775Rousan, Elobeid, Karrar, Khader, Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia, BMC Pulm. Med,
doi:10.1186/s12890-020-01286-5Schmidt, Hajage, Demoule, Pham, Combes et al., None
Shabrawishi, Al-Gethamy, Naser, Ghazawi, Alsharif et al., Clinical, radiological and therapeutic characteristics of patients with COVID-19 in Saudi Arabia, PLoS One,
doi:10.1371/journal.pone.0237130Thomson, Hunter, Dutton, Schneider, Khosravi et al., Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: A prospective observational cohort study, PLoS One,
doi:10.1371/journal.pone.0243710
